aTyr Pharma | LIFE - Sales Revenues


aTyr Pharma reported $110.08M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Ardelyx USD 125.21M 14.89M Dec/2025
aTyr Pharma USD 110.08M 109.89M Dec/2025
Biogen USD 2.28B 250M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Cipla INR 75.18B 710M Dec/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 67.33M 65.44M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Curis USD 1.14M 1.41M Dec/2025
Galapagos EUR 900.82M 835.52M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Grifols EUR 2.34B 33.3M Mar/2026
Novartis USD 13.86B 50M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
United Therapeutics USD 790.2M 9.3M Dec/2025
Xoma USD 25K 5M Sep/2024